-5%
Ondansetron is a medication that acts as a serotonin subtype 3 (5-HT3) receptor antagonist, and it is used for the following purposes:
- To prevent nausea and vomiting caused by initial and repeat courses of chemotherapy that cause nausea and vomiting (known as emetogenic cancer chemotherapy).
- To prevent and treat postoperative nausea and vomiting.
- To prevent nausea and vomiting induced by radiotherapy.
In summary, Ondansetron is used to manage nausea and vomiting caused by various medical treatments and procedures.
Emistat IM/IV-Injection is a medication that contains Ondansetron, a type of anti-emetic drug used to prevent and treat nausea and vomiting. It is particularly effective in cases of chemotherapy- or radiotherapy-induced nausea and vomiting, as well as postoperative nausea and vomiting.
However, before receiving Emistat IM/IV injection, it is important to inform your doctor if you have severe constipation, heart or liver problems, electrolyte imbalances, bowel obstruction, or if you have scheduled surgery.
Emistat IM/IV injection is not recommended for use during pregnancy, and caution should be exercised during breastfeeding since the medication may pass into breast milk. Dosage should be determined based on the patient’s age, body weight, and medical condition.
While Emistat IM/IV injection is generally well-tolerated, some common side effects may include headaches, flushing, and constipation. If any of these symptoms persist or worsen, it is important to consult your doctor.